Report Thumbnail
Product Code QY0915014488IMI
Published Date 2024/6/25
QY Research
English170 PagesGlobal

Global Contract Pharmaceutical Manufacturing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0915014488IMI◆The Jun 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/6/25
QY Research
English 170 PagesGlobal

Global Contract Pharmaceutical Manufacturing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Abstract

Summary

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global market for Contract Pharmaceutical Manufacturing was estimated to be worth US$ 87350 million in 2023 and is forecast to a readjusted size of US$ 131100 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.
The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Pharmaceutical Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Contract Pharmaceutical Manufacturing in global and regional level.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

Table of Contents

  • 1 Study Coverage

    • 1.1 Contract Pharmaceutical Manufacturing Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
      • 1.2.2 Oral
      • 1.2.3 Injectable
      • 1.2.4 API
      • 1.2.5 Other
    • 1.3 Market by Application
      • 1.3.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
      • 1.3.2 Large Enterprise
      • 1.3.3 Small Medium Enterprise
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered

  • 2 Executive Summary

    • 2.1 Global Contract Pharmaceutical Manufacturing Market Size Estimates and Forecasts
    • 2.2 Contract Pharmaceutical Manufacturing Market Size by Region: 2023 Versus 2030
      • 2.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Region: 2019-2024
      • 2.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2025-2030)
      • 2.2.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2019-2030)

  • 3 Global Contract Pharmaceutical Manufacturing by Company

    • 3.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2019-2024)
    • 3.2 Global Contract Pharmaceutical Manufacturing Revenue Share by Company (2019-2024)
    • 3.3 Competitive Landscape
      • 3.3.1 Key Contract Pharmaceutical Manufacturing Companies around the World: Ranking by Revenue
      • 3.3.2 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI) & (2019-2024)
      • 3.3.3 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.4 Global Contract Pharmaceutical Manufacturing Companies Headquarters & Product Type
      • 3.4.1 Contract Pharmaceutical Manufacturing Companies Headquarters
      • 3.4.2 Global Contract Pharmaceutical Manufacturing Companies Product & Service
      • 3.4.3 Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market
    • 3.5 Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans

  • 4 Company Profiles

    • 4.1 Catalent
      • 4.1.1 Catalent Company Information
      • 4.1.2 Catalent Description, Business Overview
      • 4.1.3 Catalent Contract Pharmaceutical Manufacturing Products Offered
      • 4.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.1.5 Catalent Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.1.6 Catalent Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.1.7 Catalent Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.1.8 Catalent Recent Developments
    • 4.2 DPx
      • 4.2.1 DPx Company Information
      • 4.2.2 DPx Description, Business Overview
      • 4.2.3 DPx Contract Pharmaceutical Manufacturing Products Offered
      • 4.2.4 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.2.5 DPx Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.2.6 DPx Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.2.7 DPx Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.2.8 DPx Recent Developments
    • 4.3 Lonza
      • 4.3.1 Lonza Company Information
      • 4.3.2 Lonza Description, Business Overview
      • 4.3.3 Lonza Contract Pharmaceutical Manufacturing Products Offered
      • 4.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.3.5 Lonza Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.3.6 Lonza Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.3.7 Lonza Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.3.8 Lonza Recent Developments
    • 4.4 Piramal Healthcare
      • 4.4.1 Piramal Healthcare Company Information
      • 4.4.2 Piramal Healthcare Description, Business Overview
      • 4.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
      • 4.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.4.5 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.4.6 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.4.7 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.4.8 Piramal Healthcare Recent Developments
    • 4.5 Aenova
      • 4.5.1 Aenova Company Information
      • 4.5.2 Aenova Description, Business Overview
      • 4.5.3 Aenova Contract Pharmaceutical Manufacturing Products Offered
      • 4.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.5.5 Aenova Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.5.6 Aenova Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.5.7 Aenova Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.5.8 Aenova Recent Developments
    • 4.6 Jubilant
      • 4.6.1 Jubilant Company Information
      • 4.6.2 Jubilant Description, Business Overview
      • 4.6.3 Jubilant Contract Pharmaceutical Manufacturing Products Offered
      • 4.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.6.5 Jubilant Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.6.6 Jubilant Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.6.7 Jubilant Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.6.8 Jubilant Recent Development
    • 4.7 Famar
      • 4.7.1 Famar Company Information
      • 4.7.2 Famar Description, Business Overview
      • 4.7.3 Famar Contract Pharmaceutical Manufacturing Products Offered
      • 4.7.4 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.7.5 Famar Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.7.6 Famar Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.7.7 Famar Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.7.8 Famar Recent Development
    • 4.8 Boehringer Ingelheim
      • 4.8.1 Boehringer Ingelheim Company Information
      • 4.8.2 Boehringer Ingelheim Description, Business Overview
      • 4.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
      • 4.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.8.5 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.8.6 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.8.7 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.8.8 Boehringer Ingelheim Recent Development
    • 4.9 Fareva Holding
      • 4.9.1 Fareva Holding Company Information
      • 4.9.2 Fareva Holding Description, Business Overview
      • 4.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
      • 4.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.9.5 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.9.6 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.9.7 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.9.8 Fareva Holding Recent Development
    • 4.10 AbbVie
      • 4.10.1 AbbVie Company Information
      • 4.10.2 AbbVie Description, Business Overview
      • 4.10.3 AbbVie Contract Pharmaceutical Manufacturing Products Offered
      • 4.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.10.5 AbbVie Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.10.6 AbbVie Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.10.7 AbbVie Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.10.8 AbbVie Recent Development
    • 4.11 Nipro Corp
      • 4.11.1 Nipro Corp Company Information
      • 4.11.2 Nipro Corp Description, Business Overview
      • 4.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products Offered
      • 4.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.11.5 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.11.6 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.11.7 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.11.8 Nipro Corp Recent Development
    • 4.12 Vetter
      • 4.12.1 Vetter Company Information
      • 4.12.2 Vetter Description, Business Overview
      • 4.12.3 Vetter Contract Pharmaceutical Manufacturing Products Offered
      • 4.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.12.5 Vetter Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.12.6 Vetter Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.12.7 Vetter Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.12.8 Vetter Recent Development
    • 4.13 Sopharma
      • 4.13.1 Sopharma Company Information
      • 4.13.2 Sopharma Description, Business Overview
      • 4.13.3 Sopharma Contract Pharmaceutical Manufacturing Products Offered
      • 4.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.13.5 Sopharma Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.13.6 Sopharma Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.13.7 Sopharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.13.8 Sopharma Recent Development
    • 4.14 DPT Laboratories
      • 4.14.1 DPT Laboratories Company Information
      • 4.14.2 DPT Laboratories Description, Business Overview
      • 4.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products Offered
      • 4.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.14.5 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.14.6 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.14.7 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.14.8 DPT Laboratories Recent Development
    • 4.15 Recipharm
      • 4.15.1 Recipharm Company Information
      • 4.15.2 Recipharm Description, Business Overview
      • 4.15.3 Recipharm Contract Pharmaceutical Manufacturing Products Offered
      • 4.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.15.5 Recipharm Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.15.6 Recipharm Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.15.7 Recipharm Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.15.8 Recipharm Recent Development
    • 4.16 NextPharma
      • 4.16.1 NextPharma Company Information
      • 4.16.2 NextPharma Description, Business Overview
      • 4.16.3 NextPharma Contract Pharmaceutical Manufacturing Products Offered
      • 4.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.16.5 NextPharma Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.16.6 NextPharma Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.16.7 NextPharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.16.8 NextPharma Recent Development
    • 4.17 Dishman
      • 4.17.1 Dishman Company Information
      • 4.17.2 Dishman Description, Business Overview
      • 4.17.3 Dishman Contract Pharmaceutical Manufacturing Products Offered
      • 4.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.17.5 Dishman Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.17.6 Dishman Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.17.7 Dishman Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.17.8 Dishman Recent Development
    • 4.18 Aesica
      • 4.18.1 Aesica Company Information
      • 4.18.2 Aesica Description, Business Overview
      • 4.18.3 Aesica Contract Pharmaceutical Manufacturing Products Offered
      • 4.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
      • 4.18.5 Aesica Contract Pharmaceutical Manufacturing Revenue by Product in 2023
      • 4.18.6 Aesica Contract Pharmaceutical Manufacturing Revenue by Application in 2023
      • 4.18.7 Aesica Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
      • 4.18.8 Aesica Recent Development

  • 5 Breakdown Data by Type

    • 5.1 Global Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
    • 5.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2025-2030)
    • 5.3 Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2030)

  • 6 Breakdown Data by Application

    • 6.1 Global Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
    • 6.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2025-2030)
    • 6.3 Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2030)

  • 7 North America

    • 7.1 North America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
    • 7.2 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
    • 7.3 North America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
    • 7.4 North America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)

  • 8 Asia-Pacific

    • 8.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
    • 8.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Region (2019-2030)
    • 8.3 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
    • 8.4 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)

  • 9 Europe

    • 9.1 Europe Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
    • 9.2 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
    • 9.3 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
    • 9.4 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)

  • 10 Latin America

    • 10.1 Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
    • 10.2 Latin America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
    • 10.3 Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
    • 10.4 Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)

  • 11 Middle East and Africa

    • 11.1 Middle East and Africa Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
    • 11.2 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
    • 11.3 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
    • 11.4 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)

  • 12 Supply Chain and Sales Channel Analysis

    • 12.1 Contract Pharmaceutical Manufacturing Supply Chain Analysis
    • 12.2 Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers
    • 12.3 Contract Pharmaceutical Manufacturing Clients Analysis
    • 12.4 Contract Pharmaceutical Manufacturing Sales Channel and Sales Model Analysis
      • 12.4.1 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Indirect Sales VS Direct Sales
      • 12.4.2 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Online Sales VS Offline Sales
      • 12.4.3 Contract Pharmaceutical Manufacturing Distributors

  • 13 Market Dynamics

    • 13.1 Contract Pharmaceutical Manufacturing Industry Trends
    • 13.2 Contract Pharmaceutical Manufacturing Market Drivers
    • 13.3 Contract Pharmaceutical Manufacturing Market Challenges
    • 13.4 Contract Pharmaceutical Manufacturing Market Restraints

  • 14 Research Findings and Conclusion

  • 15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details
    • 15.3 Disclaimer
USD 5,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.